The AJMC® Chronic Kidney Disease compendium is a comprehensive resource for clinical news and expert insights on the condition and treatment of loss of kidney function.
Kidney Tubular Secretion Associated With Faster eGFR Decline
December 22nd 2022Lower estimated tubular secretion was found to be associated with a faster decline of estimated glomerular filtration rate (eGFR) but wasn’t associated with progression of chronic kidney disease or cardiovascular disease.
Read More
DOAC Prescriptions Gradually Displaced Warfarin in AF, CKD Treatment
December 13th 2022Prescriptions for treatment of atrial fibrillation (AF) and chronic kidney disease (CKD) have primarily been prescriptions for direct oral anticoagulants (DOACs), displacing warfarin as the primary treatment.
Read More
Patients With CKD Report Burden Could Improve Through Communication With Physicians
December 7th 2022Speaking with patients diagnosed with chronic kidney disease (CKD) about the burdens associated with care could help improve understanding of the disease and their communication with health care professionals.
Read More
New Clinical Guidelines Recommend Finerenone for CKD Associated With T2D
November 21st 2022Updated Kidney Disease: Improving Global Outcomes guidelines and a consensus report with the American Diabetes Association support the use of finerenone in certain patients who have chronic kidney disease (CKD) that may be linked to type 2 diabetes (T2D).
Read More
FDA advisers voted in favor of approving Ardelyx’s tenapanor for patients with chronic kidney disease on dialysis; US home births increased by about 12% between 2020 and 2021; surges in respiratory viruses, especially respiratory syncytial virus (RSV) among younger children are putting pediatric hospitals at capacity.
Read More
Glomerular Filtration Rate Based on Cystatin C More Accurate for Predicting CVD, Mortality
November 3rd 2022A prospective population-based cohort study found that glomerular filtration rate based on cystatin C was more sensitive and specific for cardiovascular disease (CVD) and mortality risks compared with glomerular filtration rate based on creatinine.
Read More
Contributor: Congress Must Fix Patient Protection Statute Upended by Supreme Court
October 23rd 2022The author, the dean of the College of Ethnic Studies at California State University Los Angeles, says a Supreme Court ruling could upend insurance protections for patients with kidney diseases, disproportionately hurting those who are Black, Hispanic, Asian, and other diverse ethnicities.
Read More
New eGFR Formula May Inappropriately Label Black Potential Kidney Donors as Having CKD
October 7th 2022This study found that the recent change to remove race from the calculation of estimated glomerular filtration rate (eGFR) may incorrectly label potential donors who are Black as having chronic kidney disease (CKD).
Read More
Improved Air Pollution Levels Linked With Less Renal Function Decline During COVID-19 Pandemic
September 13th 2022A retrospective cohort study found that a drop in events signaling renal function decline during the COVID-19 pandemic could be associated with a decrease in fine particulate matter concentration.
Read More
Milken Institute's Sarah Wells Kocsis on How Climate Change, Aging Impact CKD Care
August 24th 2022Sarah Wells Kocsis, MBA, is co-author of the Milken Institute report, “Chronic Kidney Disease: Finding a Path to Prevention, Earlier Detection, and Management.” She spoke to The American Journal of Managed Care® about the findings of the report and how they can be incorporated into care for patients with chronic kidney disease (CKD).
Watch
SGLT2 Inhibitors, Combination Therapy Needed to Stem the Tide of CKD in Diabetes
August 20th 2022Katherine R. Tuttle, MD, FASN, FACP, FNKF, a nephrologist from the University of Washington and Providence Health Care, discussed new consensus guidelines that call for the early use of sodium glucose cotransporter 2 (SGLT2) inhibitors, GLP-1 receptor agonists, and finerenone in the care of patients with both chronic kidney disease (CKD) and diabetes.
Read More
Milken Institute's Sarah Wells Kocsis Highlights Key Findings of Her Research on CKD
August 14th 2022Sarah Wells Kocsis, MBA, is co-author of the Milken Institute report, “Chronic Kidney Disease: Finding a Path to Prevention, Earlier Detection, and Management.” She spoke to The American Journal of Managed Care® about the findings of the report and how they can be incorporated into care for patients with chronic kidney disease (CKD).
Watch